Heartland - AACE 9th Annual Meeting

Tulsa, OK US
August 10, 2018 to August 12, 2018

Welcome, and thank you for attending the Heartland Chapter of AACE 9th Annual Meeting.

The Heartland Chapter of AACE program committee has worked very hard to provide a relevant activity for the practicing clinical physician and other healthcare providers seeking education with an emphasis in endocrine disease.

This program has been planned to provide pertinent scientific and clinical information to help you achieve the best solutions in the diagnosis and therapeutic management of patients presenting with endocrine disease. Attendees will obtain updates in not only common and uncommon endocrine disorders, but also newer treatment modalities.

Providing exceptional patient care requires continuing high quality education. The American Association of Clinical Endocrinologists (AACE) was founded in 1991 by a visionary group of leaders to serve as the active voice for clinical endocrinologists. The impetus behind AACE's efforts has always been quality and cost-effective patient care for those with endocrine diseases and disorders. We hope that you will find this program of great value to you in your practice.

Target Audience

Endocrinologists, MDs & DOs, advanced practice clinicians and other healthcare professionals interested in the treatment of endocrine disease living or working in Arkansas, Kansas, Missouri, Nebraska and Oklahoma.

Learning Objectives

  1. Understand the pathophysiology of X-linked hypophosphatemic rickets (XLH)
  2. Contrast the benefits and the limitations of current XLH therapy
  3. Explore emerging use of FGF-23 antibody to treat underlying cause in XLH
  4. Understand the role of human gut microbiome
  5. Understand the relationship between gut microbiome and obesity
  6. Understand the potential therapeutic role of human microbiome in obesity
  7. Define MTC and MEN2 and review their pathophysiology
  8. Describe the clinical presentations of MTC and MEN2
  9. Discuss management of MTC and MEN2 in the context of guidelines and novel therapeutics
  10. Through the use of interactive cases, we will discuss the appropriate work up, monitoring, and treatment of advanced thyroid cancer.
  11. Identify who would benefit from seeing an eye care professional
  12. Describe and identify the levels of diabetic retinopathy
  13. Have a better understanding of the current management of advanced diabetic eye disease
  14. Reflect on the current status of telemedicine practice in endocrinology
  15. Identify a telemedicine business/practice model that would work for patients cared for by an endocrinologist
  16. Present the benefits of telemedicine for endocrinology patients
  17. Describe the available modalities for neuroendocrine tumor surveillance
  18. Identify indications and options for curative surgical therapies for neuroendocrine tumors
  19. Describe the role for surgical therapies for palliation in neuroendocrine tumors
  20. Recognize that brain injury can cause pituitary dysfunction
  21. Recognize the high incidence of pituitary dysfunction following traumatic brain injury
  22. Understands the timing of when to test for pituitary dysfunction following brain injury
  23. Demonstrate literature of the role of estrogen blockers in hypogonadism and male infertility
  24. Demonstrate the male patient type that might benefit from treatment with estrogen blockers
  25. Educate about the limitations of the use of estrogen blockers
Additional information
Available for MOC Points?: 
No
Practice Area: 
Diabetes
Nutrition
Obesity
Pituitary
Reproductive
Thyroid
Course summary
Available credit: 
  • 10.00 AMA
  • 10.00 Attendance
Course opens: 
08/10/2018
Course expires: 
08/12/2019
Event starts: 
08/10/2018 - 7:00pm
Event ends: 
08/12/2018 - 10:30am
Cost:
$0.00

MAYO HOTEL
115 W 5TH ST
TULSA, OK 74103

Friday, August 10, 2018

7:00 – 8:30 PM

Social / Dinner Program @ El Guapo

7:30 – 8:30 PM

Current and Emerging Therapies in X-linked Hypophosphatemic Rickets
Eric T. Rush, MD, FAAP, FACMG
Objectives

  1. Understand the pathophysiology of X-linked hypophosphatemic rickets (XLH)
  2. Contrast the benefits and the limitations of current XLH therapy
  3. Explore emerging use of FGF-23 antibody to treat underlying cause in XLH

Saturday, August 11, 2018

7:00 – 8:00 AM

Registration / Continental Breakfast

8:00 – 8:15 AM

Welcome / Pre-Program Assessment

8:15 – 9:15 AM

Role of Metagenomic Determinants in Childhood Obesity and Body Fat Partitioning
Nicola Santoro, MD, PhD
Objectives

  1. Understand the role of human gut microbiome
  2. Understand the relationship between gut microbiome and obesity
  3. Understand the potential therapeutic role of human microbiome in obesity
9:15 - 10:15 AM

MTC and MEN2: Past, present, and future
Steven G. Waguespack, MD, FACE
Objectives

  1. Define MTC and MEN2 and review their pathophysiology
  2. Describe the clinical presentations of MTC and MEN2
  3. Discuss management of MTC and MEN2 in the context of guidelines and novel therapeutics
10:15 – 10:45 AM

Break

10:45 - 11:45 AM

Interactive Case Discussion
Steven G. Waguespack, MD, FACE
Objectives

  1. Through the use of interactive cases, we will discuss the appropriate work up, monitoring, and treatment of advanced thyroid cancer.
11:45 – 12:45 PM

Diagnosis and Treatment of Diabetic Retinopathy 2018
Blake Cooper, MD
Objectives

  1. Identify who would benefit from seeing an eye care professional
  2. Describe and identify the levels of diabetic retinopathy
  3. Have a better understanding of the current management of advanced diabetic eye disease
12:45 – 1:45 PM

Lunch / w Presentation (Non-CME)

1:45 – 2:15 PM

Dessert Break

2:15 – 3:15 PM

Endocrinology & Telemedicine
Morgan Waller, MBA, BAPsy, BSN, RN
Objectives

  1. Reflect on the current status of telemedicine practice in endocrinology
  2. Identify a telemedicine business/practice model that would work for patients cared for by an endocrinologist
  3. Present the benefits of telemedicine for endocrinology patients
3:15 – 4:15 PM

Neuroendocrine Tumor Monitoring and Surgical Treatment
Nelson Royall, MD
Objectives

  1. Describe the available modalities for neuroendocrine tumor surveillance
  2. Identify indications and options for curative surgical therapies for neuroendocrine tumors
  3. Describe the role for surgical therapies for palliation in neuroendocrine tumors
4:15 – 4:30 PM

Post-Program Assessment

7:00 – 9:00 PM

Bowling @ Dust Bowl

Sunday, August 12, 2018

8:00 – 8:15 AM

Pre-Program Assessment

8:15 - 9:15 AM

Brain Injury and Pituitary Dysfunction
Michael Sokol, MD, FACP, FACE, CCD
Objectives

  1. Recognize that brain injury can cause pituitary dysfunction
  2. Recognize the high incidence of pituitary dysfunction following traumatic brain injury
  3. Understands the timing of when to test for pituitary dysfunction following brain injury
9:15 – 10:15 AM

Estrogen Blocking Agents in Men in the Treatment of Hypogonadism and Infertility
Ajay Nangia, MBBS, FACS
Objectives

  1. Demonstrate literature of the role of estrogen blockers in hypogonadism and male infertility
  2. Demonstrate the male patient type that might benefit from treatment with estrogen blockers
  3. Educate about the limitations of the use of estrogen blockers
10:15 – 10:30 AM

Post-Program Assessment

10:30 AM

Family Brunch

Mayo Hotel
115 W 5th St
Tulsa, OK 74103
United States

Blake Cooper, MD, FACS
Retina Associates
Shawnee, KS

Ajay K. Nangia, MBBS, FACS
Professor and Vice Chair of Dept of Urology
Director of Andrology
University of Kansas Health System
Kansas City, KS

Nelson A. Royall, MD
Assistant Professor
The University of Oklahoma School of Community Medicine
Department of Surgery
Tulsa, OK

Eric T. Rush, MD, FAAP, FACMG
Associate Professor of Pediatrics
University of Missouri - Kansas City
Associate Professor of Medicine
University of Kansas Medical Center
Kansas City, KS

Nicola Santoro, MD, PhD
Assistant Professor of Pediatrics
Yale University School of Medicine
New Haven, CT

*Michael Sokol, MD, FACP, FACE, CCD
Managing Physician Partner at the Statland Medical Group
Chairman Department of Medical Education Menorah Medical Center
Leawood, KS

Steven G. Waguespack, MD, FACE
Professor
Dept. of Endocrine Neoplasia & Hormonal Disorders
University of Texas MD Anderson Cancer Center
Houston, TX

Morgan L. Waller, MBA, BAPsy, BSN, RN
Director of Telemedicine Business & Operations
Medical Informatics & Telemedicine
Children's Mercy Kansas City
Kansas City, MO

* Indicates both a member of the Program Committee and faculty.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Association of Clinical Endocrinologists (AACE) and the Heartland Chapter of AACE. The American Association of Clinical Endocrinologists (AACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Association of Clinical Endocrinologists (AACE) designates this live activity for a maximum of 10.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 10.00 AMA
  • 10.00 Attendance

Accreditation Period

Course opens: 
08/10/2018
Course expires: 
08/12/2019

Price

Cost:
$0.00
Please login or register to take this course.